DRY AGE-RELATED MACULAR DEGENERATION
Clinical trials for DRY AGE-RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new DRY AGE-RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for DRY AGE-RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cord blood plasma eyed as treatment for blinding eye disease
Disease control Recruiting nowThis study is testing whether injections of a substance made from umbilical cord blood (called platelet-rich plasma) can slow down vision loss in people with dry age-related macular degeneration (AMD), a common cause of blindness in older adults. The treatment aims to stop or red…
Matched conditions: DRY AGE-RELATED MACULAR DEGENERATION
Phase: NA • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated May 17, 2026 07:37 UTC
-
Cord blood injection may halt dry AMD progression
Disease control Recruiting nowThis study tests whether injecting a special solution made from umbilical cord blood into the eye can slow or stop the worsening of dry age-related macular degeneration (AMD), a leading cause of vision loss. About 36 people aged 65 and older with dry AMD in both eyes will receive…
Matched conditions: DRY AGE-RELATED MACULAR DEGENERATION
Phase: NA • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated May 17, 2026 07:35 UTC
-
Stem cell therapy trial aims to halt vision loss in dry AMD
Disease control Recruiting nowThis early-stage trial tests whether transplanting special stem cells into the eye is safe for people with dry age-related macular degeneration (AMD), a leading cause of vision loss. About 18 adults over 55 with dry AMD will receive the cell transplant during eye surgery. The mai…
Matched conditions: DRY AGE-RELATED MACULAR DEGENERATION
Phase: PHASE1, PHASE2 • Sponsor: Luxa Biotechnology, LLC • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Stem cells in the eye: a new hope for dry AMD?
Disease control Recruiting nowThis study tests whether transplanting lab-grown eye cells can help treat geographic atrophy, a severe form of dry age-related macular degeneration that causes blind spots. About 20 people aged 55 and older will receive a transplant of their own stem-cell-derived retinal cells in…
Matched conditions: DRY AGE-RELATED MACULAR DEGENERATION
Phase: PHASE1, PHASE2 • Sponsor: National Eye Institute (NEI) • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Experimental eye implant aims to halt vision loss in dry AMD
Disease control Recruiting nowThis study tests an experimental implant (CPCB-RPE1) placed under the retina to treat advanced dry age-related macular degeneration with geographic atrophy. About 24 people aged 55-90 will take part, with most receiving the implant and a few receiving a sham procedure. The goal i…
Matched conditions: DRY AGE-RELATED MACULAR DEGENERATION
Phase: PHASE2 • Sponsor: Regenerative Patch Technologies, LLC • Aim: Disease control
Last updated Apr 26, 2026 19:38 UTC